Clinical trials
Phase 3 Gram-Positive Bacterial Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Basilea Pharmaceutica | 1 |
| Mannkind Corporation | 1 |
| Médecins Sans Frontières, France | 1 |
| Seres Therapeutics, Inc. | 1 |
| University of Hamburg-Eppendorf | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gram-Positive Bacterial Infections | 13 |
| Bacterial Infections | 6 |
| Bacteremia | 4 |
| Mycobacterium Infections | 2 |
| Staphylococcal Infections | 2 |
| Actinomycetales Infections | 1 |
| Bacterial Infections and Mycoses | 1 |
| Bronchiectasis | 1 |
| Clostridium Infections | 1 |
| Communicable Diseases | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.